<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Farias-Cea A</submitter><funding>Universidad de Santiago de Chile</funding><funding>Agencia Nacional de Investigación y Desarrollo</funding><funding>Universidad de La Frontera</funding><pagination>1807</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12735686</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(12)</volume><pubmed_abstract>&lt;b>Background/Objective:&lt;/b> Serotonin and dopamine are key neurotransmitters involved in regulating mood, anxiety, and locomotor activity. Specific transporters mediate their reuptake, SERT and DAT, making them targets for drugs such as Fluoxetine and Methylphenidate. Zebrafish (&lt;i>Danio rerio&lt;/i>), due to their genetic and neurochemical similarity to humans, serve as a valuable model for studying the behavioral effects of these drugs. This study aimed to compare the behavioral phenotypes induced by SERT and DAT blockers in adult zebrafish using the Novel Tank Diving Test (NTT), thereby generating a swimming profile for drugs acting on these monoamine transporters that can be utilized in drug discovery and behavior. &lt;b>Methods&lt;/b>: Adult zebrafish were administered Fluoxetine or Methylphe</pubmed_abstract><journal>Pharmaceuticals (Basel, Switzerland)</journal><pubmed_title>Distinct Swimming Behavioral Phenotypes Following Serotonin and Dopamine Transporter Modulation in the Adult Zebrafish Novel Tank Diving Test (NTT).</pubmed_title><pmcid>PMC12735686</pmcid><funding_grant_id>TD23-0016</funding_grant_id><funding_grant_id>124-0141</funding_grant_id><funding_grant_id>022401RP</funding_grant_id><funding_grant_id>124-0688</funding_grant_id><funding_grant_id>21241628</funding_grant_id><funding_grant_id>21240481</funding_grant_id><pubmed_authors>Hernandez V</pubmed_authors><pubmed_authors>Bravo JA</pubmed_authors><pubmed_authors>Leal C</pubmed_authors><pubmed_authors>Sotomayor-Zarate R</pubmed_authors><pubmed_authors>Aties-Perez C</pubmed_authors><pubmed_authors>Rojas-Hidalgo F</pubmed_authors><pubmed_authors>Iturriaga-Vasquez P</pubmed_authors><pubmed_authors>Reyes-Parada M</pubmed_authors><pubmed_authors>Julio-Pieper M</pubmed_authors><pubmed_authors>Segura K</pubmed_authors><pubmed_authors>Martinez LM</pubmed_authors><pubmed_authors>Hodar-Salazar M</pubmed_authors><pubmed_authors>Perez L</pubmed_authors><pubmed_authors>Farias-Cea A</pubmed_authors><pubmed_authors>Borroto-Escuela DO</pubmed_authors></additional><is_claimable>false</is_claimable><name>Distinct Swimming Behavioral Phenotypes Following Serotonin and Dopamine Transporter Modulation in the Adult Zebrafish Novel Tank Diving Test (NTT).</name><description>&lt;b>Background/Objective:&lt;/b> Serotonin and dopamine are key neurotransmitters involved in regulating mood, anxiety, and locomotor activity. Specific transporters mediate their reuptake, SERT and DAT, making them targets for drugs such as Fluoxetine and Methylphenidate. Zebrafish (&lt;i>Danio rerio&lt;/i>), due to their genetic and neurochemical similarity to humans, serve as a valuable model for studying the behavioral effects of these drugs. This study aimed to compare the behavioral phenotypes induced by SERT and DAT blockers in adult zebrafish using the Novel Tank Diving Test (NTT), thereby generating a swimming profile for drugs acting on these monoamine transporters that can be utilized in drug discovery and behavior. &lt;b>Methods&lt;/b>: Adult zebrafish were administered Fluoxetine or Methylphe</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-07-05T03:12:39.344Z</modification><creation>2026-07-05T03:08:19.994Z</creation></dates><accession>S-EPMC12735686</accession><cross_references><pubmed>41471296</pubmed><doi>10.3390/ph18121807</doi></cross_references></HashMap>